# A First in Human Study of ORT247 in Healthy Volunteers

> **NCT06769620** · PHASE1 · COMPLETED · sponsor: **Orthogonal Neuroscience Inc.** · enrollment: 44 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** ORT247
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06769620
- **Lead sponsor:** Orthogonal Neuroscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-06
- **Primary completion:** 2023-10-24
- **Final completion:** 2023-10-24
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06769620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06769620, "A First in Human Study of ORT247 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06769620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*